Healthcare provider profile · identity verified

Andrew Cusack, DO

Family Practice · PEORIA, IL · NPI 1578827523

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	696	181
Lisinopril	Lisinopril	428	102
Levothyroxine Sodium	Levothyroxine Sodium	390	89
Amlodipine Besylate	Amlodipine Besylate	320	84
Omeprazole	Omeprazole	291	73
Losartan Potassium	Losartan Potassium	220	57
Gabapentin	Gabapentin	186	50
Furosemide	Furosemide	174	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	163	31
Lorazepam	Lorazepam	160	35
Metoprolol Tartrate	Metoprolol Tartrate	159	33
Tamsulosin Hcl	Tamsulosin Hcl	158	35
Metoprolol Succinate	Metoprolol Succinate	143	37
Pregabalin	Pregabalin	129	25
Metformin Hcl	Metformin Hcl	127	38
Albuterol Sulfate Hfa	Albuterol Sulfate	125	37
Hydrochlorothiazide	Hydrochlorothiazide	125	35
Pantoprazole Sodium	Pantoprazole Sodium	123	32
Venlafaxine Hcl Er	Venlafaxine Hcl	123	21
Simvastatin	Simvastatin	122	31
Allopurinol	Allopurinol	118	28
Tramadol Hcl	Tramadol Hcl	116	28
Sertraline Hcl	Sertraline Hcl	113	21
Eliquis	Apixaban	112	21
Escitalopram Oxalate	Escitalopram Oxalate	107	28
Chlorthalidone	Chlorthalidone	104	20
Jardiance	Empagliflozin	101	17
Potassium Chloride	Potassium Chloride	101	21
Glimepiride	Glimepiride	97	23
Tizanidine Hcl	Tizanidine Hcl	97	35
Montelukast Sodium	Montelukast Sodium	96	26
Clopidogrel	Clopidogrel Bisulfate	92	24
Rosuvastatin Calcium	Rosuvastatin Calcium	88	23
Fluoxetine Hcl	Fluoxetine Hcl	84	14
Zolpidem Tartrate	Zolpidem Tartrate	80	14
Duloxetine Hcl	Duloxetine Hcl	79	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	20
Alprazolam	Alprazolam	67	11
Meloxicam	Meloxicam	67	20
Pravastatin Sodium	Pravastatin Sodium	66	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	12
Warfarin Sodium	Warfarin Sodium	56	suppressed
Carvedilol	Carvedilol	52	suppressed
Ezetimibe	Ezetimibe	50	13
Prednisone	Prednisone	50	34
Buspirone Hcl	Buspirone Hcl	48	12
Trazodone Hcl	Trazodone Hcl	48	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	suppressed
Metformin Hcl Er	Metformin Hcl	47	15
Xarelto	Rivaroxaban	44	suppressed
Tradjenta	Linagliptin	43	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	11
Fluticasone Propionate	Fluticasone Propionate	39	19
Alendronate Sodium	Alendronate Sodium	37	suppressed
Lovastatin	Lovastatin	37	suppressed
Propranolol Hcl Er	Propranolol Hcl	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Famotidine	Famotidine	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	13
Meclizine Hcl	Meclizine Hcl	34	11
Methocarbamol	Methocarbamol	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Atenolol	Atenolol	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Spironolactone	Spironolactone	29	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	23
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Baclofen	Baclofen	28	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Finasteride	Finasteride	24	suppressed
Linzess	Linaclotide	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	18
Januvia	Sitagliptin Phosphate	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Klor-Con M20	Potassium Chloride	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Belsomra	Suvorexant	20	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Fenofibrate	Fenofibrate,micronized	19	suppressed
Glipizide	Glipizide	19	suppressed
Diazepam	Diazepam	18	suppressed
Topiramate	Topiramate	18	suppressed
Valsartan	Valsartan	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Colchicine	Colchicine	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Azithromycin	Azithromycin	15	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Febuxostat	Febuxostat	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Ozempic	Semaglutide	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Temazepam	Temazepam	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Estradiol	Estradiol	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error